Literature DB >> 31242527

Macrophages as a Cell-Based Therapy for Liver Disease.

Philip J Starkey Lewis1, Francesca Moroni1, Stuart J Forbes1.   

Abstract

Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2019        PMID: 31242527     DOI: 10.1055/s-0039-1688502

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  13 in total

Review 1.  Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.

Authors:  Arjuna Singanayagam; Evangelos Triantafyllou
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

2.  Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo.

Authors:  Sethuraman Subramanian; Clara Jana-Lui Busch; Kaaweh Molawi; Laufey Geirsdottir; Julien Maurizio; Stephanie Vargas Aguilar; Hassiba Belahbib; Gregory Gimenez; Ridzky Anis Advent Yuda; Michaela Burkon; Jérémy Favret; Sara Gholamhosseinian Najjar; Bérengère de Laval; Prashanth Kumar Kandalla; Sandrine Sarrazin; Lena Alexopoulou; Michael H Sieweke
Journal:  Nat Immunol       Date:  2022-02-24       Impact factor: 31.250

Review 3.  Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities.

Authors:  Yankai Wen; Joeri Lambrecht; Cynthia Ju; Frank Tacke
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

4.  Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study.

Authors:  Ya-Hui Chen; Hui-Ling Chen; Cheng-Maw Ho; Hung-Yen Chen; Shu-Li Ho; Rey-Heng Hu; Po-Huang Lee; Mei-Hwei Chang
Journal:  J Pers Med       Date:  2021-04-21

Review 5.  Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint.

Authors:  Eugenia Pareja; M José Gómez-Lechón; Laia Tolosa
Journal:  Ann Transl Med       Date:  2020-04

6.  Response differences of HepG2 and Primary Mouse Hepatocytes to morphological changes in electrospun PCL scaffolds.

Authors:  Thomas S R Bate; Victoria L Gadd; Stuart J Forbes; Anthony Callanan
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

7.  Analysis of chicken macrophage functions and gene expressions following infectious bronchitis virus M41 infection.

Authors:  Xiaoqi Sun; Zheng Wang; Changhao Shao; Jia Yu; Haoyun Liu; Huijie Chen; Lu Li; Xiurong Wang; Yudong Ren; Xiaodan Huang; Ruili Zhang; Guangxing Li
Journal:  Vet Res       Date:  2021-01-28       Impact factor: 3.683

8.  Islet transplantation modulates macrophage to induce immune tolerance and angiogenesis of islet tissue in type I diabetes mice model.

Authors:  Yang Li; Xiaoming Ding; Xiaohui Tian; Jin Zheng; Chenguang Ding; Xiao Li; Xiaojun Hu; Yuxi Qiao; Ying Wang; Wujun Xue
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

9.  Infusion of Kupffer Cells Expanded in Vitro Ameliorated Liver Fibrosis in a Murine Model of Liver Injury.

Authors:  Weina Li; Fei He
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 10.  Macrophages in Zebrafish Models of Liver Diseases.

Authors:  Arkadi Shwartz; Wolfram Goessling; Chunyue Yin
Journal:  Front Immunol       Date:  2019-12-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.